Require Prescription
Description: Tecentriq is a prescription medication used for the treatment of various cancers, including certain types of lung cancer, bladder cancer, and others. It is classified as a PD-L1 (programmed death-ligand 1) blocking antibody, which works by helping the immune system fight cancer cells.
Ingredients: Each 20 mL vial contains 1200 mg of atezolizumab as the active ingredient.
Usage Instructions:
-
Dosage: The dosage and administration schedule may vary depending on the type and stage of cancer being treated, as well as individual patient factors.
-
Frequency: Typically administered intravenously (IV) every 2 or 3 weeks.
-
Special Considerations: Administration should be done under the supervision of healthcare professionals experienced in the use of cancer immunotherapy.
Benefits:
- Helps to shrink or slow the growth of tumors.
- Can improve overall survival rates in certain cancer types when used as part of a treatment regimen.
Precautions:
- Patients should be monitored for immune-related side effects, which can include pneumonitis, colitis, hepatitis, and others.
- Not recommended for use in patients with certain autoimmune diseases or active infections.
Storage Instructions:
- Store Tecentriq in the refrigerator at a temperature of 2-8°C (36-46°F).
- Protect from light.
- Do not freeze or shake vigorously.
Manufacturer:
Genentech Biotechnology corporation
